Prasad et al.’s analysis of plasma and prostate tissue samples identified 54 molecules with significantly altered expression in mice with prostate cancer revealing that NSAIDs’protective effects linked to reduced CD93 expression [171]. Here, CD93 is linked to Familial prostate cancer.